Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 762 Lung Neoplasms 339 Ovarian Neoplasms 318 Breast Neoplasms 277 Fallopian Tube Neoplasms 158 Triple Negative Breast Neoplasms 143 Small Cell Lung Carcinoma 140 Neoplasms 134 Squamous Cell Carcinoma of Head and Neck 122 Carcinoma, Ovarian Epithelial 114 Neoplasm Metastasis 84 Head and Neck Neoplasms 80 Endometrial Neoplasms 76 Uterine Cervical Neoplasms 70 Esophageal Neoplasms 70 Adenocarcinoma of Lung 68 Neuroblastoma 55 Central Nervous System Neoplasms 52 Lymphoma, Large B-Cell, Diffuse 49 Carcinoma 49 Brain Neoplasms 48 Recurrence 47 Prostatic Neoplasms 44 Parkinson Disease 4, Autosomal Dominant Lewy Body 44 Urinary Bladder Neoplasms 42 Esophageal Squamous Cell Carcinoma 41 Lymphoma 39 Melanoma 35 Carcinoma, Squamous Cell 33 Lymphoma, Non-Hodgkin 31

Interventions

ispinesib 2 trifluridine tipiracil drug combination 1 trametinib 1 tipiracil 1 irinotecan sucrosofate 1 Vincristine 1 Trifluridine 1 Temozolomide 1 TP protocol 1 SB 743921 1 Pemetrexed 1 Paclitaxel 1 PE regimen 1 Interleukin-18 1 Immunotherapy 1 Imatinib Mesylate 1 Exercise Therapy 1 Docetaxel 1 Cisplatin 1 Carboplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Solid Tumor Cancer × Carboplatin × Clear all

NCT06649448 2024-10-18

EF-001

Shandong Cancer Hospital and Institute

Phase NA Not yet recruiting

Other solid neoplasm

Solid Tumor Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡